Share this article
WASHINGTON, April 16, 2021 /PRNewswire/ Two new studies published in
Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer. According to researchers, these studies could help inform the ideal time for vaccination of these populations.
Study suggests two-dose COVID-19 vaccine is less effective for people with CLL as compared to healthy controls
The first study reports that people with CLL had markedly lower immune response rates to the two-dose mRNA COVID-19 vaccine than healthy individuals of the same age. Because clinical trials of these vaccines did not include patients with blood cancers, who are at high risk of severe illness and complications from the virus, gauging the effectiveness of the vaccine in this population is critically important.
Studies Suggest People with Blood Cancers May Not Be Optimally Protected after COVID-19 Vaccination prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Update: December, 14/2020 - 08:28 | Young actress Trúc Anh performs in Mắt Biếc (Dreamy Eyes), a film about the love story of Ngạn, a rural boy from Quảng Nam Province, and his childhood friend, Hà Lan, in the 1980s. Photo courtesy of Galaxy Studio By Thu Anh HCM CITY
Mắt Biếc (Dreamy Eyes), a production of HCM City-based film agency Galaxy Studio, will compete in the Best Foreign Language Film Category at the Oscar awards ceremony in March 2021, according to the Ministry of Culture, Sports and Tourism. The film, directed by Vietnamese-American Victor Vũ, was released in December last year. It earned a record VNĐ50 billion (US$2.1 million) in the first three days of its release and was listed among the industry’s top 10 blockbusters with more than VNĐ127 billion ($5.5 million) at the box office.